Nordson Impairment of assets held for sale remained flat by 0.0% to $3.14M in Q3 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests poor asset valuation or declining market demand for non-core business units, while a decrease indicates stable asset values or successful divestiture execution.
This represents non-cash charges recognized when the carrying value of long-lived assets held for sale exceeds their fai...
Common in large pharmaceutical companies undergoing portfolio restructuring or M&A integration.
operating_impairment_of_long_lived_assets_to_be_disposed_of| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $12.55M |